VJET · NYSE · CIK 1716621
Flyte Aviation, Inc.
Stage 1 · Must have
3/7
6 of 7 needed
Stage 2 · Refinement
9%
70% needed
Verdict
Financially weak
Rules v1.0.0
Watchlist
Saved in this browserNo companies saved yet. Use “+ Add to watchlist” to keep a company here.
Stage 1 · Must have
3 of 7 passed · at least 6 needed
Debt / Equity
Financial debt compared with shareholders' equity
Pass0.44Threshold < 1FY 2025< 1
Debt / equity: 0.44 in 2025, below the limit of 1. The company relies more on shareholders' money than on borrowing, which leaves room to absorb a weak year.
S1.1 · Source: 2025 annual report, SEC EDGAR · Original filing
Gross margin vs. industry
Gross profit as a share of revenue, compared with peers
Pass92.3%Threshold >= 60.1% (median 59.1% + 1 pp)FY 2025>= 60.1% (median 59.1% + 1 pp)
Gross margin: 92.3% in 2025, against a median of 59.1% for Medical Devices & Diagnostics (55 companies). The company keeps more of each unit of revenue after direct costs than most of its peers. A margin like this often points to a strong brand or a cost advantage.
Compared with 55 companies in Medical Devices & Diagnostics. Peer median 59.1%.
S1.2 · Source: 2025 annual report, SEC EDGAR · Original filing
Operating cash flow vs. net income
Cash from operations over reported profit, last 3 years
Failn/aThreshold > 100% (3-year sums)FY 2025> 100% (3-year sums)
Net income summed over the last 3 years is zero or negative, so there is no profit for cash flow to back up. The check counts as not met.
S1.3 · 3 annual reports used · Source: 2025 annual report, SEC EDGAR · Original filing
Free cash flow vs. net income
Cash left after investment over reported profit, last 3 years
Failn/aThreshold > 80% (3-year sums); 70-80% is closeFY 2025> 80% (3-year sums); 70-80% is close
Net income summed over the last 3 years is zero or negative, so there is no profit to turn into free cash flow. The check counts as not met.
S1.4 · 3 annual reports used · Source: 2025 annual report, SEC EDGAR · Original filing
ROIC stable and rising
Return on invested capital over 5 years
Pass-202.7%Threshold >= -273.2% (median -272.2% - 1 pp) and >= -341.3% (2020 + 0.5 pp)FY 2025>= -273.2% (median -272.2% - 1 pp) and >= -341.3% (2020 + 0.5 pp)
ROIC: -202.7% in 2025, against a median of -272.2% over 2020-2025 and -341.8% in 2020. Returns on the capital the company employs are holding up and have improved over the period, a sign of a durable business.
S1.5 · 4 annual reports used · Source: 2025 annual report, SEC EDGAR · Original filing
Return on equity vs. industry
Net income over shareholders' equity, compared with peers
Fail-243.6%Threshold >= 8.4% (median 7.4% + 1 pp)FY 2025>= 8.4% (median 7.4% + 1 pp)
Return on equity: -243.6% in 2025, against a median of 7.4% for Medical Devices & Diagnostics (55 companies). The company earns less on its shareholders' capital than the bar set by its peers. Each unit of equity produces comparatively little profit.
Compared with 55 companies in Medical Devices & Diagnostics. Peer median 7.4%.
S1.6 · Source: 2025 annual report, SEC EDGAR · Original filing
Positive EBITDA
Operating profit before depreciation and amortization
Fail-$19.0MThreshold > 0FY 2025> 0
EBITDA: -USD 19.0 million in 2025. The core business loses money even before depreciation, interest and tax, so operations rely on cash reserves or outside funding.
S1.7 · Source: 2025 annual report, SEC EDGAR · Original filing
Company snapshot
Market dataMarket data widgets by TradingView. Market prices are not part of the EdgeScore model.
Stage 2 · Refinement
1 of 11 applicable passed · at least 70% needed
SG&A stable or falling
Overhead costs as a share of revenue, over 5 years
Pass1474.4%Threshold <= 3288.4% (median 3287.9% + 0.5 pp)FY 2025<= 3288.4% (median 3287.9% + 0.5 pp)
SG&A: 1474.4% of revenue in 2025, against a median of 3287.9% over 2020-2025. Overhead costs are not growing faster than the business, a sign of cost discipline.
S2.1 · 6 annual reports used · Source: 2025 annual report, SEC EDGAR · Original filing
Interest coverage
Operating income over interest expense
Fail-3020.4xThreshold > 5FY 2025> 5
Interest coverage: -3020.4x in 2025, at or below 5. A large part of operating income goes to interest, leaving less room if profits fall.
S2.2 · Source: 2025 annual report, SEC EDGAR · Original filing
Net margin vs. industry
Net income as a share of revenue, compared with peers
Fail-2098.0%Threshold >= 8.7% (median 7.7% + 1 pp)FY 2025>= 8.7% (median 7.7% + 1 pp)
Net margin: -2098.0% in 2025, against a median of 7.7% for Medical Devices & Diagnostics (55 companies). After all costs, interest and tax, the company keeps less of its revenue as profit than the bar set by its peers.
Compared with 55 companies in Medical Devices & Diagnostics. Peer median 7.7%.
S2.3 · Source: 2025 annual report, SEC EDGAR · Original filing
ROA vs. industry
Net income over total assets, compared with peers
Fail-108.3%Threshold >= 4.1% (median 3.1% + 1 pp)FY 2025>= 4.1% (median 3.1% + 1 pp)
Return on assets: -108.3% in 2025, against a median of 3.1% for Medical Devices & Diagnostics (55 companies). The company produces less profit from the assets it holds than the bar set by its peers.
Compared with 55 companies in Medical Devices & Diagnostics. Peer median 3.1%.
S2.4 · Source: 2025 annual report, SEC EDGAR · Original filing
Current ratio
Current assets over current liabilities
Fail0.10Threshold > 1.5FY 2025> 1.5
Current ratio: 0.10 in 2025, at or below 1.5. The cushion of short-term assets over bills due within a year is thin, although some business models run this way on purpose.
S2.5 · Source: 2025 annual report, SEC EDGAR · Original filing
Total assets growing, 5 years
Average yearly growth of total assets
Fail-13.9%Threshold average growth > 0%, at most 1 year with a drop over 2%FY 2025average growth > 0%, at most 1 year with a drop over 2%
Total assets changed by -13.9% a year on average over 6 annual reports, with 4 years of decline beyond 2%. The asset base has not grown over the period, which can mean the business is shrinking or returning capital instead of reinvesting.
S2.6 · 6 annual reports used · Source: 2025 annual report, SEC EDGAR · Original filing
Free cash flow CAGR, 5 years
Average yearly growth of free cash flow
Failn/aThreshold >= 5% a yearFY 2025>= 5% a year
Free cash flow was negative or zero in 2020, so a growth rate cannot be measured from 2020 to 2025. The check counts as not met.
S2.7 · 6 annual reports used · Source: 2025 annual report, SEC EDGAR · Original filing
Quick ratio
Current assets excluding inventory over current liabilities
Fail0.08Threshold > 1FY 2025> 1
Quick ratio: 0.08 in 2025, at or below 1. Without its inventory, the company would not cover all the bills due within a year from short-term assets.
S2.8 · Source: 2025 annual report, SEC EDGAR · Original filing
Net debt / EBITDA
Years of operating profit needed to repay net debt
Failn/aThreshold < 3FY 2025< 3
EBITDA is zero or negative in 2025, so operating profit cannot pay down any debt. The check counts as not met.
S2.9 · Source: 2025 annual report, SEC EDGAR · Original filing
Positive free cash flow
Operating cash flow minus capital expenditure
Fail-$8.3MThreshold > 0FY 2025> 0
Free cash flow: -USD 8.3 million in 2025. Investment used up more cash than operations brought in, so the gap had to be covered from reserves or funding.
S2.10 · Source: 2025 annual report, SEC EDGAR · Original filing
Revenue CAGR, 5 years
Average yearly growth of revenue
Fail-28.6%Threshold >= 7% a yearFY 2025>= 7% a year
Revenue changed -28.6% a year from 2020 to 2025, below the 7% bar. Sales are growing slowly or shrinking.
S2.11 · 6 annual reports used · Source: 2025 annual report, SEC EDGAR · Original filing
Indicator guide
- Debt / Equity
- Financial debt divided by shareholders' equity shows how much of the business is funded by lenders. Below 1 means owners fund more of the company than creditors do.
- Gross margin vs. industry
- Gross margin is the share of revenue left after the direct cost of products and services. Beating the industry median by at least one point suggests pricing power or a cost advantage.
- Operating cash flow vs. net income
- Compares three years of operating cash flow with three years of reported profit. Above 100% means accounting profit is fully backed by cash coming in.
- Free cash flow vs. net income
- Free cash flow is operating cash flow minus capital spending, compared with profit over three years. Above 80% means most of the profit is cash the company can actually use.
- ROIC stable and rising
- Return on invested capital measures the profit earned on all money invested in the business, by owners and lenders. The latest value must hold near its five-year median and be higher than five years ago.
- Return on equity vs. industry
- Return on equity is net income divided by shareholders' equity. It is compared with the industry median because normal levels differ a lot between industries.
- Positive EBITDA
- EBITDA is operating profit before interest, taxes, depreciation and amortization. A positive value means the core business earns money before financing and accounting charges.
- SG&A stable or falling
- Selling, general and administrative costs as a share of revenue show how heavy the overhead is. Staying at or below the five-year median means costs are under control.
- Interest coverage
- Operating income divided by interest expense shows how easily the company pays its lenders. Above 5 leaves a wide safety margin if profits fall.
- Net margin vs. industry
- Net margin is the share of revenue that ends up as net profit. It is compared with the industry median to account for different business models.
- ROA vs. industry
- Return on assets is net income divided by total assets. It shows how efficiently the company turns everything it owns into profit, compared with its peers.
- Current ratio
- Current assets divided by current liabilities measures the ability to pay bills due within a year. Above 1.5 indicates a comfortable short-term buffer.
- Total assets growing, 5 years
- Checks that total assets grew on average over five years, with at most one sharp annual decline. The allowed decline depends on the sector, and the check is skipped for software companies.
- Free cash flow CAGR, 5 years
- The average yearly growth rate of free cash flow over five years. At least 5% a year shows the cash a business produces is growing.
- Quick ratio
- Like the current ratio, but without inventory, which can be slow to turn into cash. Above 1 means short-term debts are covered by the most liquid assets.
- Net debt / EBITDA
- Financial debt minus cash, divided by EBITDA, estimates how many years of operating earnings would repay the debt. Below 3 is generally considered manageable.
- Positive free cash flow
- Free cash flow in the latest year must be above zero. It means operations fund investment without new debt or new shares.
- Revenue CAGR, 5 years
- The average yearly growth rate of revenue over five years. At least 7% a year points to a business that keeps expanding.
Data source: SEC EDGAR, company annual reports. Original 10-K (FY 2025). Last updated Oct 29, 2026. Latest fiscal year ends Dec 31, 2025.
How the score works: EdgeScore methodology. Rules version 1.0.0.
For information and education only. Not investment advice. Data may contain errors.